Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-14

Clinical Trial Update: Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting

View source ↗

Summary

This clinical trial update reports an evaluation of predictive risk factors for chemotherapy-induced nausea and vomiting (CINV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Catholic University of Korea | Conditions: Chemotherapy-induced Nausea and Vomiting | Status: UNKNOWN